SK China, Xiaomi and Lenovo were among the investors as BYD's electric vehicle chip spinoff added $113m to the $265m it announced last month.

Continental Grain invested in a series D round that boosted the RNA technology provider's overall funding to $214m as it allocates more resources to vaccine work.

Returning investors Axel Springer and Purplebricks combined to invest $45.2m in the online real estate brokerage that will fund hiring and product development.

Next47 and M12 took part in Wandelbots' latest round, which came as it publicly launched its robotics training software tool.

The Eli Lilly and Genmab-backed RNA drug developer is now valued at nearly $1.5bn following a decision to refocus on a coronavirus vaccine.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

The Eli Lilly and Genmab-backed RNA drug developer is now valued at nearly $1.5bn following a decision to refocus on a coronavirus vaccine.

Endeavor Group is likely to sell shares in the game developer, which is near to raising money in a round that will boost its valuation from $15bn to $17bn.

Based on research from academic schools including Princeton, Chicago and Alabama at Birmingham, the oncolytic viral therapy developer has now received more than $80m to date.

The Alibaba and Telstra-backed cloud services provider has secured series F funding in what is reportedly its third nine-figure round.